Matches in Nanopublications for { ?s ?p "[Patients with p53 gene mutations showed chemoresistance (progressive disease of 42.9%, P = .0339) and a relatively poor prognosis after chemotherapy (P = .1391).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP593196.RAokgFzwrKHJ35aMTWfkuTG6nuXyk4rPyVvcgd6V4zOKA130_assertion description "[Patients with p53 gene mutations showed chemoresistance (progressive disease of 42.9%, P = .0339) and a relatively poor prognosis after chemotherapy (P = .1391).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593196.RAokgFzwrKHJ35aMTWfkuTG6nuXyk4rPyVvcgd6V4zOKA130_provenance.
- NP753500.RAVwFSyYQ878jzYLrwF0kSwWzw5tr-qI5IiTVihy69i5Y130_assertion description "[Patients with p53 gene mutations showed chemoresistance (progressive disease of 42.9%, P = .0339) and a relatively poor prognosis after chemotherapy (P = .1391).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753500.RAVwFSyYQ878jzYLrwF0kSwWzw5tr-qI5IiTVihy69i5Y130_provenance.
- assertion description "[Patients with p53 gene mutations showed chemoresistance (progressive disease of 42.9%, P = .0339) and a relatively poor prognosis after chemotherapy (P = .1391).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Patients with p53 gene mutations showed chemoresistance (progressive disease of 42.9%, P = .0339) and a relatively poor prognosis after chemotherapy (P = .1391).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP890242.RAkNkvJgQ8F9boOxUu7bW0wuZbV19Wkw1rRrdMPxYggOI130_assertion description "[Patients with p53 gene mutations showed chemoresistance (progressive disease of 42.9%, P = .0339) and a relatively poor prognosis after chemotherapy (P = .1391).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890242.RAkNkvJgQ8F9boOxUu7bW0wuZbV19Wkw1rRrdMPxYggOI130_provenance.
- NP755015.RA7xo4opFKRyg0lgcuyz8DSTfRZjC_z4PMpc3jvH84xpI130_assertion description "[Patients with p53 gene mutations showed chemoresistance (progressive disease of 42.9%, P = .0339) and a relatively poor prognosis after chemotherapy (P = .1391).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755015.RA7xo4opFKRyg0lgcuyz8DSTfRZjC_z4PMpc3jvH84xpI130_provenance.
- NP890241.RA-rgmZaufyZuYMxDrKftb1_Xzc1n5hW6ho-4nJhjQBFo130_assertion description "[Patients with p53 gene mutations showed chemoresistance (progressive disease of 42.9%, P = .0339) and a relatively poor prognosis after chemotherapy (P = .1391).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890241.RA-rgmZaufyZuYMxDrKftb1_Xzc1n5hW6ho-4nJhjQBFo130_provenance.